Scenario | Efficacy of group | Probability (groupi is larger than groupj) | ||||
Group 2 | Group 3 | Group 4 | Group 2 > group3 | Group 2 > group4 | Group 3 > group4 | |
1 | Neutral | Neutral | Neutral | 0.50 | 0.50 | 0.50 |
2 | Inferior | Neutral | Neutral | 0.06 | 0.06 | 0.50 |
3 | Neutral | Neutral | Superior | 0.50 | 0.16 | 0.16 |
4 | Inferior | Neutral | Superior | 0.07 | 0.00 | 0.16 |
5 | Neutral | Superior | Superior | 0.18 | 0.18 | 0.49 |
6 | Inferior | Superior | Superior | 0.02 | 0.02 | 0.48 |
7 | Superior | Superior | Superior | 0.48 | 0.48 | 0.48 |
8 | Neutral | Neutral | Superior | 0.50 | 0.33 | 0.33 |
9 | Inferior | Neutral | Superior | 0.04 | 0.01 | 0.39 |
Note: Neutral—no treatment effect; superior—superior to control; inferior—inferior to control. This table summarizes the proportion of trials in which a worse arm was allocated more patients than a better arm. For example, in scenario 4, group 2 (inferior to control) is allocated more patients than group 3 (no treatment effect) in 7% of trials but never allocated more patients than group 4 (superior to control). Also group 3 is allocated more patients than group 4 in 16% of trials.